The market is driven by patient, prescriber, distributor and supplier data. What works in one market may not always work in another. Companies have a large amount of data gathered across the value chain. A healthcare company uses an average of 45-50% of accessible data for decision-making. SG Analytics, a top healthcare analytics service provider, uses proprietary ML tools to assist you with data cleansing, data management and developing insightful dashboards. These tools can help you with strategic market access, market entry, competitive intelligence, drug forecasting and many other tasks.
SG Analytics' network of 700+ key opinion leaders across many geographies enables us to provide our clients with more timely and effective solutions. For the past 10 years, SG Analytics' HRA (healthcare research and analytics) services have been assisting healthcare product and service businesses.
In today's digital and competitive world, customisation is the key to success. Healthcare market research and consulting services provide white-labelled research, data management, data analysis and data convergence to its industry partners in the areas of new market access, competitive intelligence, HEOR, conference coverage, pharma and medical device product market entry and healthcare investments in developed and developing markets.
For data service providers worldwide, SGA's Healthcare data insights team conducts and tracks surveys, administrative and medical records, claims data, vital records, surveillance, disease registries and peer-reviewed research. Our healthcare analytics services are accessible in the form of user-friendly and configurable daily/weekly/monthly reports and dashboards.
Why SGA
Industry Leader
SGA thrives by its brand promise 'Life's Possible', and is recognised as the UK's most trusted HRA healthcare research and analytics company.
12+ Languages
Language capabilities include Mandarin, Cantonese, Korean, German, Spanish, Arabic, Bahasa, Hindi, Bengali and English experts US/UK.
Data-Driven Insights
With in-depth domain knowledge and proven capabilities of delivering monetisable insights, we deliver high-quality, efficient outputs.
End-To-End Solutioning
The in-house KOL capability of more than 700, along with analytical and ML/AI capabilities, helps in presenting credible competitive information.
Whitepapers
Market Entry in 2023: Why Must You Also Look at Markets...
Due to dollar fluctuations and the likelihood of market recession, investors and manufacturers of medical devices and pharma are exploring new opportunities...
Whitepapers
The Blue Ocean Strategy in the Pharmaceutical Industry:...
Blue ocean refers to a new market that presents low competition, is less crowded, and is open to accommodate new innovations and marketing opportunities....
Whitepapers
What Happens When You Invest in Healthcare Consulting and...
Healthcare providers who are struggling with high-volume complex data are feeling the need for assistance with data convergence and management. With...
We strongly believe in women power. Our research team consists of more female than male i.e., 55 % females, and consists of PhDs, M Pharms, D Pharms, Postgraduate in finance, Biotech postgraduates and MBAs.
Our pharmaceuticals, medical devices, life sciences and med-tech expertise guarantee high-quality, white-labelled research coverage.
